Antibody Production Market - Forecast(2024 - 2030)

Key Takeaways

• The market is estimated to grow at a CAGR of 12.8% owing to the rising rate of infectious diseases and increasing investments by biotechnology companies to develop treatment for various chronic diseases.

• Companies are adopting various strategic alliances to expand in various regions. Investments in antibody production and research have increased in order to develop treatment for deadly diseases such as cancer.

• Cancer treatment is observed to be more effective when multiple methods are used. Treatment methods such as stem cell transplantation along with antibody treatment has improved the survival rate of patients. Advances in biotechnology and antibody production have led to the development of various therapies for common diseases.

Process - Segment Analysis

Downstream processing is having major share by revenue in the owing to the large use of chromatography systems and resins for antibody production.  This process is highly accurate, sensitive and effective, making its use popular for the production of antibodies. 

Type - Segment Analysis

Main types of antibodies produced are monoclonal and polyclonal antibodies. Monoclonal antibodies are clones of the parent cell and Polyclonal antibodies are made from different cells. Monoclonal antibodies are dominant segment compared to polyclonal antibodies and have a CAGR of 11.2%. They are having more demand for treatment of infections, cancer, and other chronic diseases. A common method of preparation of monoclonal antibodies is using ion exchange chromatography. This is because with this method, the process can be controlled easily and has high capacity or purification capability. Ammonium sulfate precipitation is used for monoclonal and polyclonal isolation.

End-User - Segment Analysis

Pharmaceutical and biotechnological companies are having larger share by end-user segment. This is because of the production of antibodies especially for these companies and due to the high investment for research and development by such companies. 

Geography - Segment Analysis

North America accounts for largest Antibody Production market share with 32.3% in 2018. This is owing to the presence of various biotechnology companies present here. Also, the government expenditure for healthcare sector in North America is high. These factors contribute to the growth of the market in this region. However, Asia Pacific will have higher growth rate in the coming years due to supportive regulations and increasing innovations by the companies here.

Drivers – Antibody Production Market

·      Rising rate of chronic diseasesAntibodies protect body by strengthening the immune system. They are used to prevent virus or bacteria related diseases. Antibodies are produced for various infections and are given to people as immunizations. They are also being developed for treatment of cancer and arthritis. Gastric cancer is said to be the second leading cause of global cancer-related deaths. Thus the antibody production will contribute to gastroenterology. The major gastric cancer treatment antibodies include Ramucirumab and Trastuzumab.

·         Increase in expenditure by biotechnology companies

Biosimilars are gaining popularity as they serve the same purpose as the biologic and are also less expensive. With many patent expirations in the coming years, the biotechnology companies are investing in development of biosimilars. They are also increasing expenditure for research and developments for antibody production processes.

Challenges – Antibody Production Market

·         High cost of production

Antibody production requires heavy expense by the companies. Their expenditure and investments for antibody production will be high. The high cost for antibody production will challenge the market.

Antibody Production Industry Outlook

Research & development along with strategic alliances are some of the key strategies adopted by players in the Antibody Production market. Antibody Production Market top 10 companies are Cellab Gmbh, Eppendorf Ag, Integra Bioscience Ag, Merck Kgaa, Pall Corp, Sartorius Ag, Thermo Fisher Scientific, Inc, ProteoGenix, Genentech, Inc. and BIOTEM.

Antibody Production Market Research Scope:

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. These provide the key market participants with the necessary business intelligence and help them understand the future of the Antibody Production Market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats.